• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物颗粒形状对肺部渗透性和细胞摄取的影响。

Impact of drug particle shape on permeability and cellular uptake in the lung.

机构信息

Research Center Pharmaceutical Engineering GmbH, Graz, Austria.

Center for Medical Research, Medical University of Graz, Graz, Austria.

出版信息

Eur J Pharm Sci. 2019 Nov 1;139:105065. doi: 10.1016/j.ejps.2019.105065. Epub 2019 Sep 4.

DOI:10.1016/j.ejps.2019.105065
PMID:31493448
Abstract

The generation of inhalable sized particles (1-5 μm) usually involves a particle-processing step; most commonly milling but spray drying has shown to be a suitable alternative. Besides particle size, processing may affect other particle properties, like shape and solid-state. For example, spray drying of salbutamol sulphate leads to spherical shaped predominantly amorphous particles whereas jet milling frequently maintains the irregular shape and the crystallinity of the raw material. The aim of the present study was to investigate whether particle properties, especially shape, change the biological action of the inhaled particles as well. Therefore, highly water soluble salbutamol sulphate and poorly water soluble budesonide were compared regarding dissolution, permeation and preferential uptake by epithelial cells compared to macrophages after jet milling and spray drying. For both drugs the spray dried, predominantly amorphous, particles resulted in lower respirable fractions, but higher permeability and cell uptake rates compared to the needle shaped, predominantly crystalline particles. The distinct particle properties did not affect the dissolution behaviour of salbutamol sulphate. In turn for drugs with lower solubility (budesonide), spray dried particles dissolved slower compared to jet milled particles. Preferential uptake by macrophages was higher for spray dried particles, suggesting that processing may improve targeted delivery. The comparison between murine cell lines and human monocyte derived macrophages primary cells showed similar trends in rate and preference of particle uptake.

摘要

可吸入大小的颗粒(1-5μm)的生成通常涉及颗粒处理步骤;最常见的是研磨,但喷雾干燥已被证明是一种合适的替代方法。除了颗粒大小之外,处理还可能影响其他颗粒特性,例如形状和固态。例如,硫酸沙丁胺醇喷雾干燥导致球形的主要无定形颗粒,而射流磨通常保持原材料的不规则形状和结晶度。本研究的目的是研究颗粒特性,特别是形状,是否会改变吸入颗粒的生物学作用。因此,与巨噬细胞相比,对高度水溶性的硫酸沙丁胺醇和水溶性差的布地奈德进行了比较,研究了它们在射流磨和喷雾干燥后的溶解、渗透和上皮细胞优先摄取情况。对于这两种药物,喷雾干燥的、主要无定形的颗粒导致更低的可吸入分数,但与针状的、主要结晶的颗粒相比,具有更高的渗透率和细胞摄取率。不同的颗粒特性并不影响硫酸沙丁胺醇的溶解行为。对于溶解度较低的药物(布地奈德),喷雾干燥的颗粒溶解速度较慢,而射流磨的颗粒溶解速度较快。喷雾干燥的颗粒被巨噬细胞优先摄取,这表明处理可能会改善靶向输送。鼠类细胞系和人单核细胞衍生的巨噬细胞原代细胞之间的比较显示出颗粒摄取的速率和偏好性相似的趋势。

相似文献

1
Impact of drug particle shape on permeability and cellular uptake in the lung.药物颗粒形状对肺部渗透性和细胞摄取的影响。
Eur J Pharm Sci. 2019 Nov 1;139:105065. doi: 10.1016/j.ejps.2019.105065. Epub 2019 Sep 4.
2
Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.载药颗粒制剂在布地奈德和硫酸沙丁胺醇同时肺部给药中的应用。
Int J Pharm. 2013 Jan 30;441(1-2):248-54. doi: 10.1016/j.ijpharm.2012.11.036. Epub 2012 Nov 28.
3
Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.喷雾干燥法制备可吸入共无定形布地奈德-精氨酸干粉。
Int J Pharm. 2019 Jun 30;565:1-8. doi: 10.1016/j.ijpharm.2019.04.036. Epub 2019 Apr 15.
4
Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.布地奈德和茶碱吸入固体制剂的设计用于肺部联合治疗。
AAPS PharmSciTech. 2019 Mar 7;20(3):137. doi: 10.1208/s12249-019-1344-9.
5
Integration of mucus and its impact within in vitro setups for inhaled drugs and formulations: Identifying the limits of simple vs. complex methodologies when studying drug dissolution and permeability.黏液的整合及其对吸入性药物和制剂在体外模型中的影响:在研究药物溶解和渗透性时,确定简单与复杂方法学的局限性。
Int J Pharm. 2024 Aug 15;661:124455. doi: 10.1016/j.ijpharm.2024.124455. Epub 2024 Jul 8.
6
How does secondary processing affect the physicochemical properties of inhalable salbutamol sulphate particles? A temporal investigation.二次加工如何影响可吸入硫酸沙丁胺醇颗粒的物理化学性质?一项时效性研究。
Int J Pharm. 2017 Aug 7;528(1-2):416-428. doi: 10.1016/j.ijpharm.2017.06.027. Epub 2017 Jun 12.
7
Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.使用微流控反应器结合超声喷雾冷冻干燥制备的新型布地奈德干粉吸入剂颗粒
J Pharm Sci. 2017 Jul;106(7):1881-1888. doi: 10.1016/j.xphs.2017.02.035. Epub 2017 Mar 9.
8
Large porous particles for respiratory drug delivery. Glycine-based formulations.用于呼吸道药物输送的大孔颗粒。基于甘氨酸的配方。
Eur J Pharm Sci. 2017 Dec 15;110:148-156. doi: 10.1016/j.ejps.2017.05.007. Epub 2017 May 4.
9
Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate.可吸入甘露醇混合物与硫酸沙丁胺醇的摩擦带电行为。
Pharm Res. 2019 Apr 9;36(6):80. doi: 10.1007/s11095-019-2612-9.
10
Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.以具有定制表面形态的喷雾干燥甘露醇为载体和硫酸沙丁胺醇的干粉吸入器性能。
Int J Pharm. 2017 May 30;524(1-2):351-363. doi: 10.1016/j.ijpharm.2017.03.055. Epub 2017 Mar 24.

引用本文的文献

1
Nebulized 2-deoxylated glucose analogues inhibit respiratory viral infection in advanced in vitro airway models.雾化的2-脱氧葡萄糖类似物在先进的体外气道模型中可抑制呼吸道病毒感染。
Sci Rep. 2025 Mar 19;15(1):9515. doi: 10.1038/s41598-025-94476-2.
2
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
3
Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer.
用于肺部给药的纳米药物:克服呼吸道感染和肺癌治疗中的障碍
Pharmaceutics. 2024 Dec 11;16(12):1584. doi: 10.3390/pharmaceutics16121584.
4
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing.通过药物再利用靶向非小细胞肺癌中的炎症
Pharmaceuticals (Basel). 2023 Mar 16;16(3):451. doi: 10.3390/ph16030451.
5
Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence.纳米载体药物递送系统:表征、局限性、未来展望及人工智能的应用
Pharmaceutics. 2022 Apr 18;14(4):883. doi: 10.3390/pharmaceutics14040883.
6
Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design.采用析因设计法将肽-DNA 纳米粒喷雾干燥制成干粉用于肺部给药
Pharm Res. 2022 Jun;39(6):1215-1232. doi: 10.1007/s11095-022-03256-4. Epub 2022 Apr 19.
7
Drug delivery of 6-bromoindirubin-3'-glycerol-oxime ether employing poly(D,L-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents.采用聚(D,L-丙交酯-共-乙交酯)-基于纳米胶囊化技术的可持续溶剂药物递送 6-溴靛红-3'-甘油-肟醚。
J Nanobiotechnology. 2022 Jan 4;20(1):5. doi: 10.1186/s12951-021-01179-7.
8
Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19.用于靶向肺部递送的脂质体瑞德西韦吸入溶液作为治疗新冠肺炎的一种新方法。
Asian J Pharm Sci. 2021 Nov;16(6):772-783. doi: 10.1016/j.ajps.2021.09.002. Epub 2021 Oct 21.
9
Understanding Carrier Performance in Low-Dose Dry Powder Inhalation: An In VitroIn Silico Approach.了解低剂量干粉吸入剂中的载体性能:一种体外-计算机模拟方法。
Pharmaceutics. 2021 Feb 24;13(3):297. doi: 10.3390/pharmaceutics13030297.
10
Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.新型靶向慢性阻塞性肺疾病氧化应激的药物传递系统:综述。
J Nanobiotechnology. 2020 Oct 19;18(1):145. doi: 10.1186/s12951-020-00703-5.